Europol–EMCDDA Joint Report on a new psychoactive substance: 1-(3-chlorophenyl)piperazine (mCPP)

DSpace Repository


Dateien:

URI: http://hdl.handle.net/10900/87508
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-875088
http://dx.doi.org/10.15496/publikation-28894
Dokumentart: Report (Bericht)
Date: 2005
Language: English
Faculty: Kriminologisches Repository
Department: Kriminologie
DDC Classifikation: 360 - Social problems and services; associations
Keywords: Drogenmissbrauch , Drogenkonsum
Show full item record

Abstract:

In August 2005, after examining the available information collected on mCPP (1-(3-chlorophenyl)piperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint report. The report concluded that mCPP seemed unlikely to establish itself as a recreational drug in its own right and recommended that, in view of the fact that the substance was used in the manufacture of at least one medicinal product, no risk assessment should be carried out. Following the recommendations of the report, in 2006 the Commission requested an active monitoring of the substance. The Active monitoring report presents further data on mCPP and the risks it poses.

This item appears in the following Collection(s)